The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Newborn Screening and Genetic Services Market Research Report 2025

Global Newborn Screening and Genetic Services Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1803304

No of Pages : 94

Synopsis
Newborn Screening and Genetic Services encompass a range of medical tests and genetic analyses performed on newborns to detect congenital disorders, metabolic conditions, and genetic diseases early in life.
Global Newborn Screening and Genetic Services market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Newborn Screening and Genetic Services market research.
Early diagnosis and intervention for genetic and metabolic disorders are critical for newborn health. Newborn screening and genetic services aid in early detection and facilitate timely treatment and management.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Newborn Screening and Genetic Services market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Trivitron Healthcare
MASIMO CORPORATION
Covidien Plc
Nemours KidsHealth
NJ.gov
Agilent Technologies
Ge Healthcare
PERKINELMER
Natus Medical Incorporated
Waters
Bio-Rad Laboratories
Ab Sciex LLC
Segment by Type
Dry Blood Spot Tests
Hearing Screening Tests
Cchd Screening Tests
Other
Segment by Application
Clinical Laboratories
Hospitals
Other
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
The Newborn Screening and Genetic Services report covers below items:
Chapter 1: Product Basic Information (Definition, type and application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Production Region Distribution and Analysis
Chapter 4: Country Level Sales Analysis
Chapter 5: Product Type Analysis
Chapter 6: Product Application Analysis
Chapter 7: Manufacturers’ Outline
Chapter 8: Industry Chain, Market Channel and Customer Analysis
Chapter 9: Market Opportunities and Challenges
Chapter 10: Market Conclusions
Chapter 11: Research Methodology and Data Source
Index
1 Newborn Screening and Genetic Services Market Overview
1.1 Product Definition
1.2 Newborn Screening and Genetic Services Segment by Type
1.2.1 Global Newborn Screening and Genetic Services Market Value Growth Rate Analysis by Type 2022 VS 2029
1.2.2 Dry Blood Spot Tests
1.2.3 Hearing Screening Tests
1.2.4 Cchd Screening Tests
1.2.5 Other
1.3 Newborn Screening and Genetic Services Segment by Application
1.3.1 Global Newborn Screening and Genetic Services Market Value Growth Rate Analysis by Application: 2022 VS 2029
1.3.2 Clinical Laboratories
1.3.3 Hospitals
1.3.4 Other
1.4 Global Market Growth Prospects
1.4.1 Global Newborn Screening and Genetic Services Production Value Estimates and Forecasts (2018-2029)
1.4.2 Global Newborn Screening and Genetic Services Production Capacity Estimates and Forecasts (2018-2029)
1.4.3 Global Newborn Screening and Genetic Services Production Estimates and Forecasts (2018-2029)
1.4.4 Global Newborn Screening and Genetic Services Market Average Price Estimates and Forecasts (2018-2029)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Newborn Screening and Genetic Services Production Market Share by Manufacturers (2018-2023)
2.2 Global Newborn Screening and Genetic Services Production Value Market Share by Manufacturers (2018-2023)
2.3 Global Key Players of Newborn Screening and Genetic Services, Industry Ranking, 2021 VS 2022 VS 2023
2.4 Global Newborn Screening and Genetic Services Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Newborn Screening and Genetic Services Average Price by Manufacturers (2018-2023)
2.6 Global Key Manufacturers of Newborn Screening and Genetic Services, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Newborn Screening and Genetic Services, Product Offered and Application
2.8 Global Key Manufacturers of Newborn Screening and Genetic Services, Date of Enter into This Industry
2.9 Newborn Screening and Genetic Services Market Competitive Situation and Trends
2.9.1 Newborn Screening and Genetic Services Market Concentration Rate
2.9.2 Global 5 and 10 Largest Newborn Screening and Genetic Services Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Newborn Screening and Genetic Services Production by Region
3.1 Global Newborn Screening and Genetic Services Production Value Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.2 Global Newborn Screening and Genetic Services Production Value by Region (2018-2029)
3.2.1 Global Newborn Screening and Genetic Services Production Value Market Share by Region (2018-2023)
3.2.2 Global Forecasted Production Value of Newborn Screening and Genetic Services by Region (2024-2029)
3.3 Global Newborn Screening and Genetic Services Production Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.4 Global Newborn Screening and Genetic Services Production by Region (2018-2029)
3.4.1 Global Newborn Screening and Genetic Services Production Market Share by Region (2018-2023)
3.4.2 Global Forecasted Production of Newborn Screening and Genetic Services by Region (2024-2029)
3.5 Global Newborn Screening and Genetic Services Market Price Analysis by Region (2018-2023)
3.6 Global Newborn Screening and Genetic Services Production and Value, Year-over-Year Growth
3.6.1 North America Newborn Screening and Genetic Services Production Value Estimates and Forecasts (2018-2029)
3.6.2 Europe Newborn Screening and Genetic Services Production Value Estimates and Forecasts (2018-2029)
3.6.3 China Newborn Screening and Genetic Services Production Value Estimates and Forecasts (2018-2029)
3.6.4 Japan Newborn Screening and Genetic Services Production Value Estimates and Forecasts (2018-2029)
4 Newborn Screening and Genetic Services Consumption by Region
4.1 Global Newborn Screening and Genetic Services Consumption Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
4.2 Global Newborn Screening and Genetic Services Consumption by Region (2018-2029)
4.2.1 Global Newborn Screening and Genetic Services Consumption by Region (2018-2023)
4.2.2 Global Newborn Screening and Genetic Services Forecasted Consumption by Region (2024-2029)
4.3 North America
4.3.1 North America Newborn Screening and Genetic Services Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.3.2 North America Newborn Screening and Genetic Services Consumption by Country (2018-2029)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe Newborn Screening and Genetic Services Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.4.2 Europe Newborn Screening and Genetic Services Consumption by Country (2018-2029)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Newborn Screening and Genetic Services Consumption Growth Rate by Region: 2018 VS 2022 VS 2029
4.5.2 Asia Pacific Newborn Screening and Genetic Services Consumption by Region (2018-2029)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Newborn Screening and Genetic Services Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.6.2 Latin America, Middle East & Africa Newborn Screening and Genetic Services Consumption by Country (2018-2029)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Newborn Screening and Genetic Services Production by Type (2018-2029)
5.1.1 Global Newborn Screening and Genetic Services Production by Type (2018-2023)
5.1.2 Global Newborn Screening and Genetic Services Production by Type (2024-2029)
5.1.3 Global Newborn Screening and Genetic Services Production Market Share by Type (2018-2029)
5.2 Global Newborn Screening and Genetic Services Production Value by Type (2018-2029)
5.2.1 Global Newborn Screening and Genetic Services Production Value by Type (2018-2023)
5.2.2 Global Newborn Screening and Genetic Services Production Value by Type (2024-2029)
5.2.3 Global Newborn Screening and Genetic Services Production Value Market Share by Type (2018-2029)
5.3 Global Newborn Screening and Genetic Services Price by Type (2018-2029)
6 Segment by Application
6.1 Global Newborn Screening and Genetic Services Production by Application (2018-2029)
6.1.1 Global Newborn Screening and Genetic Services Production by Application (2018-2023)
6.1.2 Global Newborn Screening and Genetic Services Production by Application (2024-2029)
6.1.3 Global Newborn Screening and Genetic Services Production Market Share by Application (2018-2029)
6.2 Global Newborn Screening and Genetic Services Production Value by Application (2018-2029)
6.2.1 Global Newborn Screening and Genetic Services Production Value by Application (2018-2023)
6.2.2 Global Newborn Screening and Genetic Services Production Value by Application (2024-2029)
6.2.3 Global Newborn Screening and Genetic Services Production Value Market Share by Application (2018-2029)
6.3 Global Newborn Screening and Genetic Services Price by Application (2018-2029)
7 Key Companies Profiled
7.1 Trivitron Healthcare
7.1.1 Trivitron Healthcare Newborn Screening and Genetic Services Corporation Information
7.1.2 Trivitron Healthcare Newborn Screening and Genetic Services Product Portfolio
7.1.3 Trivitron Healthcare Newborn Screening and Genetic Services Production, Value, Price and Gross Margin (2018-2023)
7.1.4 Trivitron Healthcare Main Business and Markets Served
7.1.5 Trivitron Healthcare Recent Developments/Updates
7.2 MASIMO CORPORATION
7.2.1 MASIMO CORPORATION Newborn Screening and Genetic Services Corporation Information
7.2.2 MASIMO CORPORATION Newborn Screening and Genetic Services Product Portfolio
7.2.3 MASIMO CORPORATION Newborn Screening and Genetic Services Production, Value, Price and Gross Margin (2018-2023)
7.2.4 MASIMO CORPORATION Main Business and Markets Served
7.2.5 MASIMO CORPORATION Recent Developments/Updates
7.3 Covidien Plc
7.3.1 Covidien Plc Newborn Screening and Genetic Services Corporation Information
7.3.2 Covidien Plc Newborn Screening and Genetic Services Product Portfolio
7.3.3 Covidien Plc Newborn Screening and Genetic Services Production, Value, Price and Gross Margin (2018-2023)
7.3.4 Covidien Plc Main Business and Markets Served
7.3.5 Covidien Plc Recent Developments/Updates
7.4 Nemours KidsHealth
7.4.1 Nemours KidsHealth Newborn Screening and Genetic Services Corporation Information
7.4.2 Nemours KidsHealth Newborn Screening and Genetic Services Product Portfolio
7.4.3 Nemours KidsHealth Newborn Screening and Genetic Services Production, Value, Price and Gross Margin (2018-2023)
7.4.4 Nemours KidsHealth Main Business and Markets Served
7.4.5 Nemours KidsHealth Recent Developments/Updates
7.5 NJ.gov
7.5.1 NJ.gov Newborn Screening and Genetic Services Corporation Information
7.5.2 NJ.gov Newborn Screening and Genetic Services Product Portfolio
7.5.3 NJ.gov Newborn Screening and Genetic Services Production, Value, Price and Gross Margin (2018-2023)
7.5.4 NJ.gov Main Business and Markets Served
7.5.5 NJ.gov Recent Developments/Updates
7.6 Agilent Technologies
7.6.1 Agilent Technologies Newborn Screening and Genetic Services Corporation Information
7.6.2 Agilent Technologies Newborn Screening and Genetic Services Product Portfolio
7.6.3 Agilent Technologies Newborn Screening and Genetic Services Production, Value, Price and Gross Margin (2018-2023)
7.6.4 Agilent Technologies Main Business and Markets Served
7.6.5 Agilent Technologies Recent Developments/Updates
7.7 Ge Healthcare
7.7.1 Ge Healthcare Newborn Screening and Genetic Services Corporation Information
7.7.2 Ge Healthcare Newborn Screening and Genetic Services Product Portfolio
7.7.3 Ge Healthcare Newborn Screening and Genetic Services Production, Value, Price and Gross Margin (2018-2023)
7.7.4 Ge Healthcare Main Business and Markets Served
7.7.5 Ge Healthcare Recent Developments/Updates
7.8 PERKINELMER
7.8.1 PERKINELMER Newborn Screening and Genetic Services Corporation Information
7.8.2 PERKINELMER Newborn Screening and Genetic Services Product Portfolio
7.8.3 PERKINELMER Newborn Screening and Genetic Services Production, Value, Price and Gross Margin (2018-2023)
7.8.4 PERKINELMER Main Business and Markets Served
7.7.5 PERKINELMER Recent Developments/Updates
7.9 Natus Medical Incorporated
7.9.1 Natus Medical Incorporated Newborn Screening and Genetic Services Corporation Information
7.9.2 Natus Medical Incorporated Newborn Screening and Genetic Services Product Portfolio
7.9.3 Natus Medical Incorporated Newborn Screening and Genetic Services Production, Value, Price and Gross Margin (2018-2023)
7.9.4 Natus Medical Incorporated Main Business and Markets Served
7.9.5 Natus Medical Incorporated Recent Developments/Updates
7.10 Waters
7.10.1 Waters Newborn Screening and Genetic Services Corporation Information
7.10.2 Waters Newborn Screening and Genetic Services Product Portfolio
7.10.3 Waters Newborn Screening and Genetic Services Production, Value, Price and Gross Margin (2018-2023)
7.10.4 Waters Main Business and Markets Served
7.10.5 Waters Recent Developments/Updates
7.11 Bio-Rad Laboratories
7.11.1 Bio-Rad Laboratories Newborn Screening and Genetic Services Corporation Information
7.11.2 Bio-Rad Laboratories Newborn Screening and Genetic Services Product Portfolio
7.11.3 Bio-Rad Laboratories Newborn Screening and Genetic Services Production, Value, Price and Gross Margin (2018-2023)
7.11.4 Bio-Rad Laboratories Main Business and Markets Served
7.11.5 Bio-Rad Laboratories Recent Developments/Updates
7.12 Ab Sciex LLC
7.12.1 Ab Sciex LLC Newborn Screening and Genetic Services Corporation Information
7.12.2 Ab Sciex LLC Newborn Screening and Genetic Services Product Portfolio
7.12.3 Ab Sciex LLC Newborn Screening and Genetic Services Production, Value, Price and Gross Margin (2018-2023)
7.12.4 Ab Sciex LLC Main Business and Markets Served
7.12.5 Ab Sciex LLC Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Newborn Screening and Genetic Services Industry Chain Analysis
8.2 Newborn Screening and Genetic Services Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Newborn Screening and Genetic Services Production Mode & Process
8.4 Newborn Screening and Genetic Services Sales and Marketing
8.4.1 Newborn Screening and Genetic Services Sales Channels
8.4.2 Newborn Screening and Genetic Services Distributors
8.5 Newborn Screening and Genetic Services Customers
9 Newborn Screening and Genetic Services Market Dynamics
9.1 Newborn Screening and Genetic Services Industry Trends
9.2 Newborn Screening and Genetic Services Market Drivers
9.3 Newborn Screening and Genetic Services Market Challenges
9.4 Newborn Screening and Genetic Services Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’